Pnc Financial Services Group, Inc. Vanda Pharmaceuticals Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 96 shares of VNDA stock, worth $424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96
Previous 145
33.79%
Holding current value
$424
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding VNDA
# of Institutions
154Shares Held
43.8MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.4 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $250M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...